Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

OREX 5.01
price chart
Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker
Orexigen Therapeutics (NASDAQ: OREX ) has been the darling of the obesity drugmakers, doing something Arena Pharmaceuticals (NASDAQ: ARNA ) and VIVUS (NASDAQ: VVUS ) weren't able to do: keep its share price above where it was when its ...
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More  Xconomy
Why It's Lights Out for Orexigen Therapeutics, Inc.
What: Shares of Orexigen Therapeutics (NASDAQ: OREX ) , a biopharmaceutical company focused on developing therapies to treat obesity, saw its own valuation slim down by as much as 13% during Tuesday's trading session after it and its partner Takeda ...
Takeda Threatens to End Orexigen Partnership After Study Halted  Bloomberg
Orexigen Terminates Required Study for Diet Drug Contrave  Wall Street Journal
Biotech Stock News: Orexigen Therapeutics, Inc. (OREX), Vertex ...
On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had to be terminated early.
Orexigen Therapeutics Retains Prescribers' And Analysts' Support (OREX)
Speculation still abounds among investors regarding Orexigen Therapeutics, Inc. (NASDAQ:OREX) and its Light Study, the cardiovascular outcomes trial (CVOT) that was terminated early last week.
Biotech Orexigen Therapeutics (NASDAQ:OREX) Shifts its Focus to Hardcore ...  WallStreet.org
Why Orexigen Therapeutics, Inc. Lost a Sixth of Its Value in April
What: Shares of Orexigen Therapeutics (NASDAQ: OREX ) , a biopharmaceutical company engaged in the development of therapies for chronic weight management, lost 16% in April, or a sixth of its market value according to data from S&P Capital IQ, after it ...
Orexigen Therapeutics Inc (NASDAQ:OREX) in Spotlight  Street Report
Foresite Capital Betting It All On These Four Healthcare Stocks  Insider Monkey (blog)
Why Orexigen Therapeutics, Inc. (OREX), Gap Inc. (GPS) and Rackspace ...
Orexigen185 Why Orexigen Therapeutics, Inc. (OREX), Gap Inc. (GPS The ink didn't even have a chance to fully dry on last week's encouraging first quarter earnings report from Orexigen Therapeutics before Murphy's Law kicked in and upended OREX ...
Stock's Negative Trend: Interphase (NASDAQ:INPH), Orexigen Therapeutics ...  wsnewspublishers
Orexigen Plummets After Release Of 50% Interim Results, But Is This The End?  Seeking Alpha
Biogen Inc, Gilead Sciences, Inc., Orexigen Therapeutics, Inc.: Best Biotech ...
“Earlier, Biogen had initiated a project with Fitbit, using the company's activity trackers to gather data on MS patients,” Money Morning's Defense and Tech Specialist Michael Robinson said.
Most Active Stocks In Focus: PulteGroup, Inc. (NYSE:PHM), Orexigen ...
Orexigen Therapeutics, Inc., issued the statement regarding the termination of the Light Study a cardiovascular (CV) outcomes trial that compared the obesity drug Contrave´┐Ż (naltrexone HCI and bupropion HCl extended-release tablets) to placebo, ...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ...
To: All persons or entities who purchased Orexigen Therapeutics, Inc. stock OREX, -0.86% between March 3, 2015 and March 5, 2015.
OREXIGEN SHAREHOLDERS: Shareholder Rights Law Firm Reminds Investors ...  Business Wire (press release)
Enter your email address:  Stockhouse
Stock in Motion: Orexigen Therapeutics, Inc. (NASDAQ:OREX)
Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares opened the most recent trading session at 4.990 and at the time of writing the last Bid was at 5.065.